Effort to Curb Rising Generic Drug Costs Reaches Congress.

The article discusses a proposed legislation that would rein in skyrocketing generic drug prices and require drug manufacturers to pay a rebate to Medicaid when their generic prices increase at a rate that outpaces inflation. The federal bill is seen as a response to concerns by physicians, hospitals and patients about drug manufacturers who increase generic drugs prices without an explanation. It cites an investigation by the Office of the Inspector General on the rising prices of generics.